Glycosbio
Houston, US · Delaware corporation · 3 known investors
Biotech
Founders & leadership
JW
Joseph WalowskiDirector
VN
Victoria NiklasDirector
RC
Richard C. Jr. CilentoExecutive Officer, Director
DW
Dan WatkinsDirector
FF
Frank FosterDirector
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$1.1MraisedMar 2024 · 5 investors · BiotechnologyRule 506(b)
▶$1.1MraisedMar 2024 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Victoria NiklasDirector
- John ReplogleDirector
- Richard C. Jr. CilentoExecutive Officer, Director
- Frank FosterDirector
- Joseph WalowskiDirector
- Offering amount
- $5M
- Amount sold
- $1.1M
- Minimum investment
- $25K
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$425KraisedApr 2023 · 3 investors · BiotechnologyRule 506(b)
▶$425KraisedApr 2023 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph WalowskiDirector
- Victoria NiklasDirector
- Richard C. Jr. CilentoExecutive Officer, Director
- Dan WatkinsDirector
- Frank FosterDirector
- Offering amount
- $1M
- Amount sold
- $425K
- Minimum investment
- $25K
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$829.8KraisedJan 2017 · 15 investors · Other TechnologyRule 506(b)
▶$829.8KraisedJan 2017 · 15 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Frank FosterDirector
- Richard C. CilentoExecutive Officer, Director
- Steve JurvetsonDirector
- Offering amount
- $930K
- Amount sold
- $829.8K
- Minimum investment
- $8K
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.